Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1983 Jan;49(1):83–89. doi: 10.1136/hrt.49.1.83

Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging.

B Hockings, S Saltissi, D N Croft, M M Webb-Peploe
PMCID: PMC485214  PMID: 6821615

Abstract

Nine patients with stable angina (group 1) underwent maximal treadmill stress testing and thallium-201 (201T1) myocardial scintigraphy after intravenous propranolol hydrochloride, and after placebo. Though seven of the nine patients exercised longer after propranolol than after placebo, this difference did not reach statistical significance. Propranolol, however, significantly reduced the mean maximum rate pressure product. Comparison of the perfusion scans on and off propranolol showed that in 36 out of 90 of the myocardial segments recorded (nine patients, five segments scanned twice per patient), only one of the scans showed a defect. In 24 out of 36 of these the propranolol scan was negative, the defect appearing in the placebo scan. Defects present on both scans but differing significantly in size occurred in 22 out of 54 view pairs (nine patients, three views after exercise and three views after redistribution on propranolol and on placebo), and in 19 of these the smaller defect was seen in the propranolol scan. In one of the nine patients, the propranolol scan was normal (false negative), whereas defects corresponding to angiographically proven coronary artery lesions were seen on the placebo scan. Six patients (group 2) were maximally exercised after propranolol and then re-exercised to the same rate pressure product on placebo. Again 16 out of 60 of the segment pairs disagreed and in 10 of these the unmatched defect was present on the placebo scan. In 10 out of 14 discrepant view pairs, the smaller defect occurred on the propranolol scan. Thus in patients taking propranolol, negative results do not exclude coronary artery disease, and perfusion defects (if present) though accurately reflecting the presence of disease may underestimate its true extent.

Full text

PDF
83

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albro P. C., Gould K. L., Westcott R. J., Hamilton G. W., Ritchie J. L., Williams D. L. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial. Am J Cardiol. 1978 Nov;42(5):751–760. doi: 10.1016/0002-9149(78)90094-2. [DOI] [PubMed] [Google Scholar]
  2. Alderman E. L., Coltart D. J., Wettach G. E., Harrison D. C. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med. 1974 Nov;81(5):625–627. doi: 10.7326/0003-4819-81-5-625. [DOI] [PubMed] [Google Scholar]
  3. Becker L. C., Fortuin N. J., Pitt B. Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res. 1971 Feb;28(2):263–269. doi: 10.1161/01.res.28.2.263. [DOI] [PubMed] [Google Scholar]
  4. Bruce R. A., Hornsten T. R. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis. 1969 Mar;11(5):371–390. doi: 10.1016/0033-0620(69)90027-9. [DOI] [PubMed] [Google Scholar]
  5. Bruce R. A., Hossack H. F., Kusumi F., Clarke L. J. Acute effects of oral propranolol on hemodynamic responses to upright exercise. Am J Cardiol. 1979 Jul;44(1):132–140. doi: 10.1016/0002-9149(79)90262-5. [DOI] [PubMed] [Google Scholar]
  6. Hamilton G. W., Narahara K. A., Yee H., Ritchie J. L., Williams D. L., Gould K. L. Myocardial imaging with thallium-201: effect of cardiac drugs on myocardial images and absolute tissue distribution. J Nucl Med. 1978 Jan;19(1):10–16. [PubMed] [Google Scholar]
  7. Jorgensen C. R., Wang K., Wang Y., Gobel F. L., Nelson R. R., Taylor H. Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise. Circulation. 1973 Dec;48(6):1173–1182. doi: 10.1161/01.cir.48.6.1173. [DOI] [PubMed] [Google Scholar]
  8. McLaughlin P. R., Martin R. P., Doherty P., Daspit S., Goris M., Haskell W., Lewis S., Kriss J. P., Harrison D. C. Reproducibility of thallium-201 myocardial imaging. Circulation. 1977 Mar;55(3):497–503. doi: 10.1161/01.cir.55.3.497. [DOI] [PubMed] [Google Scholar]
  9. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  10. Nelson R. R., Gobel F. L., Jorgensen C. R., Wang K., Wang Y., Taylor H. L. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation. 1974 Dec;50(6):1179–1189. doi: 10.1161/01.cir.50.6.1179. [DOI] [PubMed] [Google Scholar]
  11. Pohost G. M., Alpert N. M., Ingwall J. S., Strauss H. W. Thallium redistribution: mechanisms and clinical utility. Semin Nucl Med. 1980 Jan;10(1):70–93. doi: 10.1016/s0001-2998(80)80030-4. [DOI] [PubMed] [Google Scholar]
  12. Weich H. F., Strauss H. W., Pitt B. The extraction of thallium-201 by the myocardium. Circulation. 1977 Aug;56(2):188–191. doi: 10.1161/01.cir.56.2.188. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES